Organovo Holdings Files S-1 with SEC
Ticker: VIVS · Form: S-1 · Filed: Oct 25, 2024 · CIK: 1497253
| Field | Detail |
|---|---|
| Company | Organovo Holdings, Inc. (VIVS) |
| Form Type | S-1 |
| Filed Date | Oct 25, 2024 |
| Risk Level | medium |
| Pages | 15 |
| Reading Time | 18 min |
| Key Dollar Amounts | $0, $0.001, $1 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, s-1, registration
TL;DR
Organovo Holdings just filed an S-1, get ready for potential stock action.
AI Summary
Organovo Holdings, Inc. filed an S-1 registration statement with the SEC on October 25, 2024. The company, formerly known as Real Estate Restoration & Rental, Inc. until July 22, 2010, is incorporated in Delaware and headquartered in San Diego, California. This filing indicates a move towards public offering or significant corporate action.
Why It Matters
This S-1 filing signals Organovo Holdings' intent to potentially raise capital or undergo a significant corporate event, impacting its future operations and investor landscape.
Risk Assessment
Risk Level: medium — S-1 filings are often precursors to significant corporate events like IPOs or secondary offerings, which carry inherent market and execution risks.
Key Numbers
- 333-282841 — SEC File Number (Identifies the specific SEC registration)
- 0001497253 — Central Index Key (Unique identifier for the company in SEC filings)
Key Players & Entities
- Organovo Holdings, Inc. (company) — Registrant
- Real Estate Restoration & Rental, Inc. (company) — Former Company Name
- 20100722 (date) — Date of Name Change
- 20241025 (date) — Filing Date
- Keith Murphy (person) — Executive Chairman
- 11555 Sorrento Valley Road, Suite 100 San Diego, CA 92121 (address) — Principal Executive Offices
FAQ
What is the primary purpose of this S-1 filing for Organovo Holdings, Inc.?
The S-1 filing is a registration statement required by the SEC for companies planning to offer securities to the public, indicating potential for an IPO, secondary offering, or other significant capital-raising event.
When was Organovo Holdings, Inc. previously known by another name?
Organovo Holdings, Inc. was formerly known as Real Estate Restoration & Rental, Inc., with the name change occurring on July 22, 2010.
Where are Organovo Holdings, Inc.'s principal executive offices located?
The company's principal executive offices are located at 11555 Sorrento Valley Road, Suite 100, San Diego, CA 92121.
Who is listed as the Executive Chairman of Organovo Holdings, Inc. in this filing?
Keith Murphy is listed as the Executive Chairman of Organovo Holdings, Inc.
What is the Standard Industrial Classification (SIC) code for Organovo Holdings, Inc.?
The SIC code for Organovo Holdings, Inc. is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Filing Stats: 4,618 words · 18 min read · ~15 pages · Grade level 13.6 · Accepted 2024-10-25 17:00:42
Key Financial Figures
- $0 — d to the public in this offering, minus $0.001, and the exercise price of each pre
- $0.001 — rice of each pre-funded warrant will be $0.001 per share. The pre-funded warrants will
- $1 — ment to maintain a minimum bid price of $1 per share, as set forth in Nasdaq Listi
Filing Documents
- onvo_s1_october_2024.htm (S-1) — 664KB
- onvo-ex23_1.htm (EX-23.1) — 8KB
- onvo-ex23_2.htm (EX-23.2) — 4KB
- onvo-exfiling_fees.htm (EX-FILING FEES) — 53KB
- img73068057_0.jpg (GRAPHIC) — 12KB
- img73068057_1.jpg (GRAPHIC) — 12KB
- 0000950170-24-117458.txt ( ) — 763KB
Use of Proceeds
Use of Proceeds 14 Capitalization 15
Description of Capital Stock
Description of Capital Stock 19
Description of Securities We Are Offering
Description of Securities We Are Offering 23 Material U.S. Federal Income Tax Considerations for Non-U.S. Holders 26 Plan of Distribution 31 Legal Matters 36 Experts 36 Incorporation of Certain Information By Reference 37 Where You Can Find More Information 38 Disclosure of Commission Position on Indemnification for Securities Act Liabilities 39 i About this Prospectus You should rely only on the information contained in this prospectus. We have not authorized anyone to provide you with information other than the information that we have provided or incorporated by reference in this prospectus and your reliance on any unauthorized information or representation is at your own risk. This prospectus may be used only in jurisdictions where offers and sales of these securities are permitted. You should assume that the information appearing in this prospectus is accurate only as of the date of this prospectus, regardless of the time of delivery of this prospectus, or any sale of our securities. Our business, financial condition and results of operations may have changed since those dates. The information appearing in this prospectus and any free writing prospectus that we have authorized for use in connection with this offering is accurate only as of its respective date, regardless of the time of delivery of the respective document or of any sale of securities covered by this prospectus. You should not assume that the information contained in this prospectus, or in any free writing prospectus that we have authorized for use in connection with this offering, is accurate as of any date other than the respective dates thereof. We further note that the representations, warranties and covenants made by us in any agreement that is filed as an exhibit to any document that is incorporated by reference herein were made solely for the benefit of the parties to such agreement, including, in some cases, for the purpose of allocating risk among